Sustained virological response in chronic Hep C patients treated with combination therapy
The latest issue of the Alimentary Pharmacology & Therapeutics evaluates the durability of sustained virological response in chronic Hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral.
fiogf49gjkf04
The introduction of direct-acting anti-virals has increased sustained virological response rates
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .